ArticleMolecular therapy. Methods & clinical development2020

Myostatin Is a Quantifiable Biomarker for Monitoring Pharmaco-gene Therapy in Duchenne Muscular Dystrophy.

Virginie Mariot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.